Project Grant H79SM090810

The Department of Health and Human Services Substance Abuse and Mental Health Services Administration awarded Centerstone Research Institute, Inc. $800,000 on September 30, 2026, under the Center for Mental Health Services Projects of Regional and National Significance program (CFDA 93.532).

The project, ZS-EXPAND, will strengthen suicide prevention services across the Centerstone Health System, serving adults at risk for suicide in 152 counties across seven states. Over the five-year period of performance through September 29, 2031, 46,215 individuals will receive comprehensive suicide risk assessments, with approximately 12,000 enrolled in tailored care pathways and suicide care management plans. The initiative implements evidence-based screening, safety planning, lethal means counseling, brief cognitive behavioral therapy for suicide prevention, and dialectical behavior therapy. Project goals include integrating the Zero Suicide Framework systemwide, expanding workforce training, improving identification and treatment of suicide risk, ensuring warm handoffs during care transitions, and using continuous quality improvement to strengthen policies, practices, and patient outcomes.

Place of performance is Nashville, Tennessee. Centerstone Research Institute, Inc. is a nonprofit health system providing mental health and substance use disorder treatments through outpatient clinics, residential programs, telehealth, and inpatient hospital services.